High Burden of Antimicrobial Resistance among Major Bacterial Pathogens in Bangui, Central African Republic: A Study Based on Data from a National Laboratory, 2013-2019
Introduction: Antimicrobial resistance (AMR) is now one of the major threats to global public health, with a particularly significant impact in resource-limited countries. The availability of reliable local data is essential to guide treatment and surveillance policies. The objective of this study was to describe the bacteriological and antibiotic resistance profiles observed at the National Laboratory of Clinical Biology and Public Health (LNBCSP) in Bangui. Patients and Methods: This is a descriptive study based on the analysis of aggregated microbiological data from the LNBCSP's routine tables covering the period 2013–2019. The results were analyzed in terms of the distribution of bacterial species and overall antibiotic susceptibility and resistance profiles. Results: A total of 3,020 bacterial isolates were analyzed. Staphylococcus aureus was the most frequently isolated species, followed by Escherichia coli and Klebsiella pneumoniae. High levels of resistance were observed for several commonly used antibiotics, including cotrimoxazole, penicillins, and fluoroquinolones. Conclusion: The results indicate a high burden of antimicrobial resistance in Bangui and highlight the urgent need to strengthen microbiological surveillance and the proper use of antibiotics.
References
[1]
European Antimicrobial Resistance Collaborators (2023) The Burden of Bacterial Antimicrobial Resistance in the WHO European Region in 2019: A Cross-Country Systematic Analysis. The Lancet Public Health, 7, e897-e913. https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(22)00225-0/fulltext
[2]
Goenka, S., Jain, M., Wanswett, W., Loomba, P., Sharma, A. and Mishra, B. (2025) Carbapenem-Resistant Acinetobacter Baumannii: Prevalence, Phenotypic and Genotypic Analysis in Cases of Ventilator Associated Pneumonia from a Teaching Hospital in Delhi, India. IndianJournalofMedicalMicrobiology, 56, Article ID: 100894. https://doi.org/10.1016/j.ijmmb.2025.100894
[3]
Robert, M., Corvec, S., Andreo, A., Gallou, F.L., Marquot, G., Mangeant, R., et al. (2025) Epidemiological and Bacteriological Trends from 2013 to 2023 of Carbapenemase-Producing Enterobacterales (CPE) in a French University Hospital: A Permanent Risk of Outbreak. InfectiousDiseasesNow, 55, Article ID: 105021. https://doi.org/10.1016/j.idnow.2024.105021
[4]
Laudet, F., Dutronc, H., Fabre, T., Meynard, P. and Costes, S. (2025) La vancomycine topique utilisée au cours des prothèses de hanche ou de genou de première intention a-t-elle un effet protecteur vis-à-vis de la survenue d’infection? RevuedeChirurgieOrthopédiqueetTraumatologique, 111, 208-219. https://doi.org/10.1016/j.rcot.2024.09.001
[5]
Bousquet, A. and Mérens, A. (2021) Scientific Report: Bacteriological Diagnosis of Multi-Drug-Resistant Bacteria and Emerging Highly Resistant Bacteria.
[6]
Olivier, M., Sandrine, B., Julien, E. and Olivier, K. (2023) Incidence des infections associées aux soins en 2022 au centre hospitalier de Haguenau. Revue Francophone des Laboratoires, 2023, 62-69. https://doi.org/10.1016/s1773-035x(23)00217-4
[7]
Igbinosa, O., Dogho, P. and Osadiaye, N. (2020) Carbapenem-Resistant Enterobacteriaceae: A Retrospective Review of Treatment and Outcomes in a Long-Term Acute Care Hospital. AmericanJournalofInfectionControl, 48, 7-12. https://doi.org/10.1016/j.ajic.2019.07.006
[8]
Mascitti, H. and Jaffal, K. (2021) Bon usage des antibiotiques, infections à bactéries multirésistantes et nouvelles molécules. InfectiousDiseasesNow, 51, 51/8S1-51/8S5. https://doi.org/10.1016/s2666-9919(21)00554-6
[9]
Coignard, B. (2019) Antibiorésistance: La situation en France et dans le monde. Bulletindel’AcadémieNationaledeMédecine, 203, 159-169. https://doi.org/10.1016/j.banm.2019.02.006
[10]
Da, L., Somé, D., Yehouenou, C., Somé, C., Zoungrana, J., Ouédraogo, A., et al. (2023) État des lieux de la résistance aux antibiotiques en Afrique subsaharienne. MédecineetMaladiesInfectieusesFormation, 2, 3-12. https://doi.org/10.1016/j.mmifmc.2023.01.003
[11]
Tattevin, P., Levy Hara, G., Toumi, A., Enani, M., Coombs, G., Voss, A., et al. (2020) Advocacy for Increased International Efforts for Antimicrobial Stewardship Actions in Low-And Middle-Income Countries on Behalf of Alliance for the Prudent Use of Antimicrobials (APUA), under the Auspices of the International Society of Antimicrobial Chemotherapy (ISAC). FrontiersinMedicine, 7, Article 503. https://doi.org/10.3389/fmed.2020.00503
[12]
Djeintote, M., Lango-Yaya, E., Vogbia, Z., Rafaï, C.D., Balekouzou, A., Djemer, H.S., et al. (2024) Antibiotic Resistance Profile of Salmonella Strains Isolated at the National Clinical Biology and Public Health Laboratory in Bangui, Central African Republic. Health, 16, 160-171. https://doi.org/10.4236/health.2024.162014
[13]
Breurec, S., Rafaï, C., Onambele, M., Frank, T., Farra, A., Legrand, A., et al. (2018) Serotype Distribution and Antimicrobial Resistance of Shigella Species in Bangui, Central African Republic, from 2002 to 2013. TheAmericanJournalofTropicalMedicineandHygiene, 99, 283-286. https://doi.org/10.4269/ajtmh.17-0917
[14]
Rafaï, C., Frank, T., Manirakiza, A., Gaudeuille, A., Mbecko, J., Nghario, L., et al. (2015) Dissemination of Incf-Type Plasmids in Multiresistant CTX-M-15-Producing Enterobacteriaceae Isolates from Surgical-Site Infections in Bangui, Central African Republic. BMCMicrobiology, 15, Article No. 15. https://doi.org/10.1186/s12866-015-0348-1
[15]
Vogbia, Z., Lango Yaya, E., Colette-Nganda Banguet, M., de Dieu Longo, J.,-Rafaï, C., Ouoko Fa-Tigbia, M.A.A., et al. (2023) Contribution to the Study of Antibiotic Sensitivity of Streptococcus pneumoniae Strains in Spinal Cerebral Fluids in Bangui from 2017 to 2022. JournalofBiomedicalScienceandEngineering, 16, 95-106. https://doi.org/10.4236/jbise.2023.167007
[16]
Lango-Yaya, E. (2016) Molecular Diagnosis of Streptococcus pneumoniae Acute Meningitis and Profile of Sensitivity of Usual Antibiotics in Bangui, Central African Republic at the National Clinical Biology and Public. International Journal of Research Studies in Microbiology and Biotechnology (IJRSMB), 2, 1-8. https://doi.org/10.20431/2454-9428.0204001
[17]
Ollandzobo Ikobo, L.C., Pea, E.A., Ngakengni, N.Y., Ekouya Bowassa, G. and Mbika Cardorelle, A. (2022) Prescription des antibiotiques chez le nouveau-né hospitalisé à Brazzaville. JournaldePédiatrieetdePuériculture, 35, 29-35. https://doi.org/10.1016/j.jpp.2021.12.004
[18]
Charani, E., Smith, I., Skodvin, B., Perozziello, A., Lucet, J., Lescure, F., et al. (2019) Investigating the Cultural and Contextual Determinants of Antimicrobial Stewardship Programmes across Low-, Middle-and High-Income Countries—A Qualitative Study. PLOSONE, 14, e0209847. https://doi.org/10.1371/journal.pone.0209847
[19]
Marzouk, M., Toumi, N., Ben Hadj Hassine, A., Haj Ali, M. and Boukadida, J. (2016) Profil et sensibilité aux antibiotiques de 5187 bactéries uropathogènes en Tunisie. MédecineetMaladiesInfectieuses, 46, 330-332. https://doi.org/10.1016/j.medmal.2016.05.001
[20]
Sirinavin, S. and Dowell, S.F. (2004) Antimicrobial Resistance in Countries with Limited Resources: Unique Challenges and Limited Alternatives. SeminarsinPediatricInfectiousDiseases, 15, 94-98. https://doi.org/10.1053/j.spid.2004.01.012
[21]
Dia, N.M., Ka, R., Dieng, C., Diagne, R., Dia, M.L., Fortes, L., et al. (2008) Résultats de l’enquête de prévalence des infections nosocomiales au CHNU de Fann (Dakar, Sénégal). Médecine et Maladies Infectieuses, 38, 270-274. https://doi.org/10.1016/j.medmal.2007.11.001
[22]
Lepelletier, D., Batard, E., Berthelot, P., Zahar, J., Lucet, J., et al. (2015) Maîtrise de la diffusion des entérobactéries productrices de carbapénémases: épidémiologie, stratégies de prévention et enjeux. LaRevuedeMédecineInterne, 36, 474-479. https://doi.org/10.1016/j.revmed.2014.12.006
[23]
Le Moing, V., Bonnet, É., Cattoir, V., Chirouze, C., Deconinck, L., Duval, X., et al. (2025) Antibiothérapie et antibioprophylaxie de l’endocardite infectieuse—Une prise de position SPILF-AEPEI sur les recommandations 2023 de l’ESC. MédecineetMaladiesInfectieusesFormation, 4, 25-41. https://doi.org/10.1016/j.mmifmc.2024.11.071
[24]
Pialleport, T., Dard, L., Ciotti, C., Tabut, J. and Lecointe, D. (2020) Le métier de biohygiéniste: Un atout pour l’équipe opérationnelle d’hygiène, un atout pour le laboratoire d’hygiène hospitalière. RevueFrancophonedesLaboratoires, 2020, 30-38. https://doi.org/10.1016/s1773-035x(20)30271-9
[25]
Picot, S., Rakotomalala, R.S., Farny, K., Simac, C. and Michault, A. (2010) Évolution de la résistance aux antibiotiques de 1997 à 2005 à la Réunion. Médecine et Maladies Infectieuses, 40, 617-624. https://doi.org/10.1016/j.medmal.2010.04.001
[26]
Fournel, I., Tiv, M., Soulias, M., Hua, C., Astruc, K. and Aho Glélé, L.S. (2009) E-07 Prévention des infections du site opératoire: Efficacité de la povidone iodée en peropératoire. MédecineetMaladiesInfectieuses, 39, S32. https://doi.org/10.1016/s0399-077x(09)74358-6
[27]
Chalfine, A. (2004) Prévention et surveillance des infections du site opératoire. LePraticienenAnesthésieRéanimation, 8, 156-165. https://doi.org/10.1016/s1279-7960(04)98185-5
[28]
Ferroni, A., Péjin, Z., Odent, T., Cadilhac, C., Berche, P. and Glorion, C. (2010) Infections ostéo-articulaires aiguës de l’enfant: Place du microbiologiste. ArchivesdePédiatrie, 17, 766-767. https://doi.org/10.1016/s0929-693x(10)70100-7
[29]
Honoré, S., Lascols, C., Malin, D., Targaouchi, R., Cattoir, V., Legrand, P., et al. (2006) Émergence et diffusion chez les entérobactéries du nouveau mécanisme de résistance plasmidique aux quinolones Qnr (résultats hôpital Henri-Mondor 2002-2005). PathologieBiologie, 54, 270-279. https://doi.org/10.1016/j.patbio.2005.11.001
[30]
Lahlou Amine, I., Chegri, M. and L’Kassmi, H. (2009) Épidémiologie et résistance aux antibiotiques des entérobactéries isolées d’infections urinaires à l’hôpital militaire Moulay-Ismail de Meknès. Antibiotiques, 11, 90-96. https://doi.org/10.1016/j.antib.2008.10.004
